chrisvoncsefalvay/vaers-outcomes huggingface dataset:
Vaccine went into 2-8 Celsius thaw state on or about 24-Dec-2021 and administered on 18-Feb-2022; Vaccine went into 2-8 Celsius thaw state on or about 24-Dec-2021 and administered on 18-Feb-2022; This spontaneous case was reported by an emergency medical technician and describes the occurrence of EXPIRED PRODUCT ADMINISTERED (Vaccine went into 2-8 Celsius thaw state on or about 24-Dec-2021 and administered on 18-Feb-2022) and PRODUCT STORAGE ERROR (Vaccine went into 2-8 Celsius thaw state on or about 24-Dec-2021 and administered on 18-Feb-2022) in a 64-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 066H21A) for COVID-19 vaccination.     No Medical History information was reported.    On 18-Feb-2022 at 1:20 PM, the patient received third dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) .25 milliliter. On 18-Feb-2022 at 1:20 PM, the patient experienced EXPIRED PRODUCT ADMINISTERED (Vaccine went into 2-8 Celsius thaw state on or about 24-Dec-2021 and administered on 18-Feb-2022). On an unknown date, the patient experienced PRODUCT STORAGE ERROR (Vaccine went into 2-8 Celsius thaw state on or about 24-Dec-2021 and administered on 18-Feb-2022). At the time of the report, EXPIRED PRODUCT ADMINISTERED (Vaccine went into 2-8 Celsius thaw state on or about 24-Dec-2021 and administered on 18-Feb-2022) and PRODUCT STORAGE ERROR (Vaccine went into 2-8 Celsius thaw state on or about 24-Dec-2021 and administered on 18-Feb-2022) outcome was unknown.        For mRNA-1273 (Moderna COVID-19 Vaccine) (Unknown), the reporter did not provide any causality assessments.    Census Ethnicity of the patient was reported.  Concomitant medication of the patient was not reported.  Vaccine administration time was given as 13:20:05.  No treatment information was provided by the reporter.   This case was linked to MOD-2022-542869 (Patient Link).
At 4:00pm I got lightheaded, dizzy, and achy. The lightheadedness was such that my heart was pounding, vision was lost for a second (similar to the effect when you stand up too fast), and the sound went out for a second. Around 7:00 I got chills, a 101 degree F fever, and headache. The chills, fever, and headache lasted throughout the night, but they were gone in the morning. The entire day after getting the vaccine, 4/1/2021, I had a metallic taste in my mouth. By the morning of 4/2/2021 the metallic taste was gone.
received the Moderna vaccine 14 days apart.; This spontaneous case was reported by an other health care professional and describes the occurrence of INAPPROPRIATE SCHEDULE OF PRODUCT ADMINISTRATION (received the Moderna vaccine 14 days apart.) in a 24-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch nos. 037D21A and 037D21A) for COVID-19 vaccination.     The patient's past medical history included No adverse event (No medical history reported).   On 07-Apr-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. On 23-Apr-2021, received second dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) dosage was changed to 1 dosage form. On 23-Apr-2021, the patient experienced INAPPROPRIATE SCHEDULE OF PRODUCT ADMINISTRATION (received the Moderna vaccine 14 days apart.). On 23-Apr-2021, INAPPROPRIATE SCHEDULE OF PRODUCT ADMINISTRATION (received the Moderna vaccine 14 days apart.) had resolved. Not Provided      For mRNA-1273 (Moderna COVID-19 Vaccine) (Unknown), the reporter did not provide any causality assessments.
Extreme fatigue for two weeks following each vaccination, loss of menstrual cycle for 8 months (amenorrhea), cystic acne along jaw line and neck which has not improved, thinning hair which seems to be worsening.
Mother called stating that her son received a shot 2/24/04 to his left arm and the arm is now swollen and itching. Mom states she has been placing hot packs to the arm for 2 days.
April 6, 2021 first inoculation. April 27, 2021, second shot. Both were administered at 10 am in the left arm. April 28 2021 awakened between 2 to 3 am ?on fire,? the left side more intense than elsewhere but feeling like he was being pricked all over with hot pins. This abated over the next 24 hours and continued to subside during the following several days.  May 21, 2021 While spending a weekend at a cabin he experienced a feeling that the left side of his face was ?sliding off? and the fire ramped up along the left side of his face and forearm. He checked for symptoms of a stroke but found no motor complications. He has continued to have a low level of these sensations (the hot pins) which intermittently ?ramp up? and sometimes extend from the left into the right side. He says that he can live with this but doesn?t want to experience greater problems if he gets the booster. They are surface sensations which remind him of his three episodes of shingles,
Female pt. Age 66. RA since 1972. Taking Actemra infusions monthly. I received 3 Pfizer COVID vaccines spaced by 6 mo intervals with no side effects, then rheumatologist recommended I get a Moderna for cross immunity. Immunized with Moderna on 05/23/2022. 28MAY, I began having more joint pain which grew into a major flare; pain level: 7. Small joints very swollen. Needed Norco to relieve pain. Had Actemra infusion 03JUNE. Still in flare. My rheumatologist is away on vacation. Having an acute flare in the small joints of my hands which are already severely damaged was counter-productive.
Information has been received from a physician and a licensed Practical nurse concerning a pt who was vaccinated with a dose of Pneumococcal 23v polysaccharide vaccine. Subsequently the pt developed cellulitis. Unspecified medical attention was sought. After several days, the pt recovered. No product quality complaint was involved. Additional information has been requested.
Very heavy period began, 2 weeks ahead of schedule.  Much heavier bleeding began after about 12 hours and has continued for 3 days.   This level of bleeding is not typical.  Many blood clots have also been passed.
pt recvd Engerix-B 19AUG92 & AUG92 reported feeling poorly, head pounding, profuse sweating, temp, stomach sickness, joint aching, felt drained; sx resolved w/in 6 hrs;
fatigue; chills; Pain at injection; This spontaneous case was reported by a consumer and describes the occurrence of FATIGUE (fatigue), CHILLS (chills) and VACCINATION SITE PAIN (Pain at injection) in a 79-year-old patient of an unknown gender who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch nos. 012M20A and 012M20A) for COVID-19 vaccination.     The patient's past medical history included No adverse event.   On 27-Jan-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On 27-Jan-2021, received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) dosage was changed to 1 dosage form. On 27-Jan-2021, the patient experienced VACCINATION SITE PAIN (Pain at injection). On 28-Jan-2021, the patient experienced FATIGUE (fatigue) and CHILLS (chills). The patient was treated with PARACETAMOL (TYLENOL) at an unspecified dose and frequency. On 29-Jan-2021, FATIGUE (fatigue), CHILLS (chills) and VACCINATION SITE PAIN (Pain at injection) had resolved.        The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) was unknown.       No relevant concomitant medications were reported.
Started physical therapy so she could walk; Sometimes bones hurt worse; Physical therapy helps when she has more pain; This case was reported by a consumer via other manufacturer and described the occurrence of walking difficulty in a 72-year-old female patient who received Herpes zoster (Shingrix) for prophylaxis.   The patient's past medical history included back surgery (the patient was in hospital for back surgery in January 2020 and was told to stop taking medication 2 weeks before and 2 weeks after), foot surgery, shingles (4 months after back surgery), pernicious anemia (most recent) and conjunctivitis. Previously administered products included Shingles shot with an associated reaction of herpes zoster (received 5 years ago), COVID-19 VACCINE MODERNA (1st dose received in left arm on 30th March 2021, lot number 018B21A), COVID-19 VACCINE MODERNA (2nd dose received in left arm on 29th April 2021, lot number 043B21A), vitamin B12 (received every months), METHOTREXATE (received in May 2019 (2.5 mg, 8 tablets by mouth once a week)) and Xeljanz (received on 30th October 2020, (unknown dose once daily by mouth) not taking for a year). Concurrent medical conditions included rheumatoid arthritis, goiter, warthin's tumor (biopsy of right salivary gland lesion in 2019), graves' disease (was in remission, so patient's eyes were doing better) and bone pain. Concomitant products included Herpes zoster (Shingrix) and cyanocobalamin (Vitamin B12).   On 9th September 2021, the patient received the 2nd dose of Shingrix. In September 2021, less than 3 weeks after receiving Shingrix and an unknown time after receiving Shingrix, the patient experienced walking difficulty, bone pain aggravated and pain. On an unknown date, the outcome of the walking difficulty, bone pain aggravated and pain were unknown.   It was unknown if the reporter considered the walking difficulty, bone pain aggravated and pain to be related to Shingrix.  Additional details were provided as follows: The patient self-reported this case. The patient had stopped taking Methotrexate when she started taking shingles vaccine. The patient received Vitamin B12 shot every month. On 14th June 2021, the patient received the 1st dose of Shingrix. The patient received 2nd dose of Shingrix vaccine and experienced sometimes bones hurt worse on certain days, started physical therapy so she could walk. Physical therapy helped to the patient when she had more pain. The patient's blood pressure and potassium went wacko. The patient was currently prescribed with Xeljanz XR 11 mg. The last time the patient went to the doctor, he asked if she ever played cards and then said she had the worst hand dealt. No lot number or expiry date was reported for Shingrix The reporter consented to follow up with her and her healthcare professional. No further details were reported.
COVID 19 Treatment; COVID 19 Treatment; This is a spontaneous report received from a non-contactable reporter(s) (Other HCP). The reporter is the patient.  A 32-year-old female patient (not pregnant) received BNT162b2 (BNT162B2), as dose 3 (booster), single (Batch/Lot number: unknown) for covid-19 immunisation; coviD-19 vaccine (COVID-19 VACCINE), as dose 1, single (Batch/Lot number: unknown) and as dose 2, single (Batch/Lot number: unknown) for covid-19 immunisation. The patient's relevant medical history and concomitant medications were not reported. The following information was reported: DRUG INEFFECTIVE (medically significant), COVID-19 (medically significant), outcome "unknown" and all described as "COVID 19 Treatment". The patient underwent the following laboratory tests and procedures: SARS-CoV-2 test: Positive. Therapeutic measures were taken as a result of drug ineffective, covid-19.  No follow-up attempts are possible; information about lot/batch number cannot be obtained. No further information is expected.; Sender's Comments: The vaccine efficacy varies from one patient to another and can be affected by different factors; however, a contributory role of the suspect vaccine BNT162B2 to drug ineffectiveness and COVID-19 cannot be ruled out.
At 4:00 am on 8-14-2015 pt was awaken with pain at site of injection, no redness, no swelling and bil-hands burning and itching. Pt seen in clinic at 9:00 a,. Bil hands still burn and itch- red pain side 6/10-Tx from BENADRYL and prednisone. Symptoms worse. Instructed to RTC if not resolving.
This case was reported by a physician to a sales rep and described the occurrence of headache in a female subject of unspecified age who was vaccinated with tetanus toxoid, reduced diphtheria toxoid and acellular pertussis vaccine, adsorbed (Boostrix) plus a separate injection of meningococcal polysaccharide conjugate vaccine (Menactra). On 26Apr06 the subject received a dose of Boostrix plus a separate injection of Menactra in different arms. The lot numbers for Boostrix and Menactra were not provided. On either 26Apr06 or 27Apr06, less than one week after vaccination with Boostrix and Menactra, the subject experienced a headache. The subject also experienced severe arm soreness in the Menactra arm. The outcome of the events was not reported.
Lost feeling her face; Left arm went numb; Pain still in her left arm; Left arm is tired; Left arm is weak; Heart rate went high; Blotchy; Red; Itchy; This spontaneous case was reported by an other health care professional and describes the occurrence of HYPOAESTHESIA (Lost feeling her face), HYPOAESTHESIA (Left arm went numb), PAIN IN EXTREMITY (Pain still in her left arm), LIMB DISCOMFORT (Left arm is tired) and MUSCULAR WEAKNESS (Left arm is weak) in a 39-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 027L20A) for COVID-19 vaccination. The occurrence of additional non-serious events is detailed below.     No Medical History information was reported.    On 19-Jan-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On 19-Jan-2021, the patient experienced HYPOAESTHESIA (Lost feeling her face), HYPOAESTHESIA (Left arm went numb), PAIN IN EXTREMITY (Pain still in her left arm), LIMB DISCOMFORT (Left arm is tired), MUSCULAR WEAKNESS (Left arm is weak), HEART RATE INCREASED (Heart rate went high), RASH MACULAR (Blotchy), ERYTHEMA (Red) and PRURITUS (Itchy). The patient was treated with PARACETAMOL (TYLENOL) for Adverse event, at an unspecified dose and frequency and DIPHENHYDRAMINE HYDROCHLORIDE (BENADRYL [DIPHENHYDRAMINE HYDROCHLORIDE]) for Adverse event, at an unspecified dose and frequency. At the time of the report, HYPOAESTHESIA (Lost feeling her face), HYPOAESTHESIA (Left arm went numb), PAIN IN EXTREMITY (Pain still in her left arm), LIMB DISCOMFORT (Left arm is tired), MUSCULAR WEAKNESS (Left arm is weak), HEART RATE INCREASED (Heart rate went high), RASH MACULAR (Blotchy), ERYTHEMA (Red) and PRURITUS (Itchy) outcome was unknown.        The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) was unknown.   For mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular), the reporter did not provide any causality assessments.   Treatment information also included physical therapy.  No concomitant medication was provided.
Fully vax, no booster- tested positive for Covid-19 on Binax rapid antigen test 1/21/22.
Symptoms started about 5 pm and included temp of 103.5 and muscle/joint aches. She took TYLENOL for high fever and later developed chills and sweating. High fever and aches were intense overnight and lessened over the next 3 days.
advised not to take second dose of vaccine; cancelled the second dose; big red whelps on front and back of thighs, appeared on arms; This spontaneous case was reported by a patient and describes the occurrence of URTICARIA (big red whelps on front and back of thighs, appeared on arms), INCOMPLETE COURSE OF VACCINATION (advised not to take second dose of vaccine) and PRODUCT DOSE OMISSION ISSUE (cancelled the second dose) in an 82-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 013L20A) for COVID-19 vaccination.     Concurrent medical conditions included Allergy to venom (insect venom), Dust allergy (dust), Pollen allergy (pollen), Allergy to molds (mold), Asthma and Heart disease, unspecified. Concomitant products included ALBUTEROL SULFATE, ACETYLSALICYLIC ACID (ASPIRIN), ATORVASTATIN, BIOTIN, FLUTICASONE FUROATE, VILANTEROL TRIFENATATE (BREO ELLIPTA), CALCIUM CARBONATE, COLECALCIFEROL (CALCIUM CARBONATE AND VITAMIN D3), CENTRUM SILVER, DILTIAZEM HYDROCHLORIDE (DILTIAZEM CD), EPINEPHRINE, ESTRIOL SUCCINATE (ESTRIOL), POLYCARBOPHIL CALCIUM (FIBERCON), FLUTICASONE PROPIONATE, LEVOTHYROXINE, MONTELUKAST SODIUM (MONTELUKAST), MIRABEGRON (MYRBETRIQ), SALBUTAMOL SULFATE (PROAIR HFA), DENOSUMAB (PROLIA), TOBRAMYCIN, PARACETAMOL (TYLENOL), VITAMIN C [ASCORBIC ACID] (VITAMIN C), CETIRIZINE HYDROCHLORIDE (ZYRTEC) and DIPHENHYDRAMINE HYDROCHLORIDE (BENADRYL [DIPHENHYDRAMINE HYDROCHLORIDE]) for an unknown indication.    On 15-Jan-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On 17-Jan-2021, the patient experienced URTICARIA (big red whelps on front and back of thighs, appeared on arms). On an unknown date, the patient experienced INCOMPLETE COURSE OF VACCINATION (advised not to take second dose of vaccine) and PRODUCT DOSE OMISSION ISSUE (cancelled the second dose). The patient was treated with METHYLPREDNISOLONE at a dose of 4 mg. On 21-Jan-2021, URTICARIA (big red whelps on front and back of thighs, appeared on arms) had resolved. At the time of the report, INCOMPLETE COURSE OF VACCINATION (advised not to take second dose of vaccine) and PRODUCT DOSE OMISSION ISSUE (cancelled the second dose) had resolved.        mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) was withdrawn on an unknown date.       One of the treatment medication included Dospak 215   Most recent FOLLOW-UP information incorporated above includes: On 26-Apr-2021: No specific follow-up information recorded. On 08-Jun-2021: No significant information was received.
Blood clot in liver one month later. Had to take blood thinners for 6 months and be evaluated every 1-4 weeks.
sweating; tiredness; no appetite; headache; body aches; a rash on both arms; just laying in the bed pretty much; This is a spontaneous report received from a contactable consumer (patient). A 71-yearsold male patient received second dose of (PFIZER-BIONTEC COVID-19 VACCINE, Solution for injection, Lot Number and expiry date were not provided), via an unspecified route of administration on 12Apr2021 (at age of 71-years-old) as a single dose for covid-19 immunisation. The patient's medical history and concomitant medication were not reported. Patient had previously received first dose of vaccine on 15Mar2021 and did not have any side effects. It was reported that patient did not start having any side effects until Wednesday of last week, 19May2021, and he is concerned because of the length of time that has passed since he received his second dose and the onset of side effects. On unspecified date, patient experienced sweating, tiredness, no appetite, headache and body aches, was just laying in the bed pretty much and a rash on both arms. The rash was a little bit worse in the arm which he received his vaccine. He also states that his symptoms were improving and he does feel better. Patient wanted to know if it was normal to have side effects 3 weeks after getting the second shot and reported that he goes to the hospital for all of his medical needs. Reporter seriousness for unspecified side effects three weeks after getting second injection was unspecified. The outcome for all events was resolving.  Information on Lot/Batch number has been obtained. Additional Information has been requested.
C/O "lips tingling". After continued observation Benedryl  PO given. Dc'd home 30 mins .
Deep venous thrombosis of the left upper extremity axillary, brachial and ulnar veins; Superficial thrombophlebitis of cephalic and basilic veins of the left upper extremity; This is a spontaneous report from a non-contactable consumer (patient). A 43-years-old female patient received bnt162b2 (PFIZER-BIONTECH COVID-19 VACCINE, formulation: Solution for injection, Batch/Lot Number: EW0168), via an unspecified route of administration on 20Jul2021 (at the age of 43-years-old) as dose number unknown, single for covid-19 immunisation. The patient medical history, medications within 2 weeks of vaccination and concomitant medications were not reported. Known allergies for penicillin were reported. Prior to vaccination patient was not diagnosed with COVID-19. The patient did not receive any vaccines within four weeks prior to the vaccination. On 22Jul2021, the patient experienced superficial thrombophlebitis of cephalic and basilic veins of the left upper extremity and deep venous thrombosis of the left upper extremity axillary, brachial and ulnar veins. Adverse events resulted in doctor or other healthcare professional office/clinic visit. Patient had received treatment for event was Eliquis. Outcome of the events was recovering.  No follow-up attempts are possible. No further information is expected.
Arm is very swollen; Hurts a lot; This spontaneous case was reported by a consumer and describes the occurrence of PERIPHERAL SWELLING (Arm is very swollen) and MYALGIA (Hurts a lot) in a patient of an unknown age and gender who received mRNA-1273 (Moderna COVID-19 Vaccine) for COVID-19 vaccination.     No Medical History information was reported.   On an unknown date, the patient received second dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On an unknown date, received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) dosage was changed to 1 dosage form. On an unknown date, the patient experienced PERIPHERAL SWELLING (Arm is very swollen) and MYALGIA (Hurts a lot). At the time of the report, PERIPHERAL SWELLING (Arm is very swollen) and MYALGIA (Hurts a lot) outcome was unknown.            No concomitant product use was provided by the reporter.  No treatment medication was provided.  Action take with mRNA-1273 in response to the event was not applicable.
I developed severe myocarditis and pericarditis which I was admitted and received treatment for after receiving the Covid-19 vaccine.
PATIENT REFERS THAT 15 MINUTES AFTER VACCINATION SHE EXPERIENCED HEADACHE, STOMACH ACHE AND DIFFICULTY BREATHING.
This spontaneous report as received from a registered nurse refers to a multiple unspecified patients of unknown age and gender. On an unknown date, the patients were vaccinated with doses of (Merck) VARIVAX (lot # L010144 exp date 24-MAR-2017) (dose and route not reported) that were improperly stored. No adverse effects were reported. Additional information has been requested.
Narrative: Pt is an 87 YO male with PMH afib, CHF, anemia, CKD, DM, IHD, HTN, GERD, and Barret's esophagus seen by palliative care for HTN heart disease w/ HFrEF & CKD 3b. Per Regulatory Authority, pt's daughter reported t hat he passed away at home.
Child received DTaP, HIB; Hep B vaccines on 4/29/10 and reported to ER that night with hives. Child seen in our office on 4/30/10 for urticaria. Tx'd with BENADRYL. Injection sites look benign.
sickle cell patient w/o splenectomy exp an inject site react; no rash present;
24 hours after the vaccination high fever and sore arm and could not move my arm and notice in 24 hours the lymphedema swelling and is still swollen and been having chronic issues since January and is getting another ultrasound in January.
Information has been received on 09-JUL-2018 regarding a case in litigation from a lawyer and a female consumer of unknown age. The patient's concurrent conditions, medical history and concomitant medications are unknown. In 2014, the patient was inoculated with ZOSTAVAX (lot number and expiration unknown) unknown route, at a physician's office as recommended for routine adult health maintenance for the prevention of shingles. The vaccine did not prevent shingles as intended, and the patient subsequently contracted a persistent strain condition of herpes zoster. In 2015, the patient was treated by a physician for a blistering vesicular outbreak, which was diagnosed as severe herpes zoster or shingles. As a direct and proximate result of the ZOSTAVAX and/or despite receiving the ZOSTAVAX for long-term prevention of shingles, the patient suffered painful injuries and damages, and required extensive medical care and treatment. As a further proximate result, the patient has suffered and will continue to suffer significant medical expenses and pain and suffering and other damages. Additional information has been requested.